90 related articles for article (PubMed ID: 11483905)
1. A randomized, double-blind placebo-controlled trial of the effects of the 5-hydroxytriptamine(4) agonist cisapride on the female urinary bladder.
Steele AC; Walsh P; Bentley M; Neff J; Karram M
Am J Obstet Gynecol; 2001 Jul; 185(1):62-4. PubMed ID: 11483905
[TBL] [Abstract][Full Text] [Related]
2. The effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. A randomized, double-blind, placebo-controlled study.
Madeiro AP; Rufino AC; Sartori MG; Baracat EC; Lima GR; Girão MJ
Int Urogynecol J Pelvic Floor Dysfunct; 2006 May; 17(3):248-52. PubMed ID: 15959612
[TBL] [Abstract][Full Text] [Related]
3. [Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].
Hermieu JF;
Prog Urol; 2007 Nov; 17(6 Suppl 2):1264-84. PubMed ID: 18214138
[TBL] [Abstract][Full Text] [Related]
4. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder.
Ohlstein EH; von Keitz A; Michel MC
Eur Urol; 2012 Nov; 62(5):834-40. PubMed ID: 22695239
[TBL] [Abstract][Full Text] [Related]
6. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.
Amarenco G; Ismael SS; Even-Schneider A; Raibaut P; Demaille-Wlodyka S; Parratte B; Kerdraon J
J Urol; 2003 Jun; 169(6):2210-5. PubMed ID: 12771752
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
8. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
9. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619
[TBL] [Abstract][Full Text] [Related]
10. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.
Ghei M; Maraj BH; Miller R; Nathan S; O'Sullivan C; Fowler CJ; Shah PJ; Malone-Lee J
J Urol; 2005 Nov; 174(5):1873-7; discussion 1877. PubMed ID: 16217327
[TBL] [Abstract][Full Text] [Related]
11. Randomized Controlled Trial to Assess the Impact of Intraurethral Lidocaine on Urodynamic Voiding Parameters.
Kisby CK; Gonzalez EJ; Visco AG; Amundsen CL; Grill WM
Female Pelvic Med Reconstr Surg; 2019; 25(4):265-270. PubMed ID: 29300256
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an experimental urodynamic platform to identify treatment effects: a randomized, placebo-controlled, crossover study in patients with overactive bladder.
Frenkl T; Railkar R; Shore N; Bailen J; Sutherland S; Burke J; Scott BB; Ruddy M; Beals C
Neurourol Urodyn; 2012 Jan; 31(1):69-74. PubMed ID: 21905086
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting detrusor contraction strength during voiding in women.
Karram MM; Partoll L; Bilotta V; Angel O
Obstet Gynecol; 1997 Nov; 90(5):723-6. PubMed ID: 9351752
[TBL] [Abstract][Full Text] [Related]
14. The effects of 4 weeks treatment with cisapride on cystometric parameters in spinal cord injury patients. A double-blind, placebo controlled study.
Wyndaele JJ; Van Kerrebroeck P
Paraplegia; 1995 Nov; 33(11):625-7. PubMed ID: 8584295
[TBL] [Abstract][Full Text] [Related]
15. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study.
Gacci M; Del Popolo G; Macchiarella A; Celso M; Vittori G; Lapini A; Serni S; Sandner P; Maggi M; Carini M
J Urol; 2007 Nov; 178(5):2040-3; discussion 2044. PubMed ID: 17869296
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
17. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.
Nitti VW; Rosenberg S; Mitcheson DH; He W; Fakhoury A; Martin NE
J Urol; 2013 Oct; 190(4):1320-7. PubMed ID: 23727415
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
Sahai A; Khan MS; Dasgupta P
J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
[TBL] [Abstract][Full Text] [Related]
19. Striated urethral sphincter activity does not alter urethral pressure during filling cystometry.
Kenton K; Fitzgerald MP; Brubaker L
Am J Obstet Gynecol; 2005 Jan; 192(1):55-9. PubMed ID: 15672003
[TBL] [Abstract][Full Text] [Related]
20. Parameters of bladder function in pre-, peri-, and postmenopausal continent women without detrusor overactivity.
Pfisterer MH; Griffiths DJ; Rosenberg L; Schaefer W; Resnick NM
Neurourol Urodyn; 2007; 26(3):356-61. PubMed ID: 17285577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
